Gehring M - Search Results

1

The current contribution of molecular factors to risk estimation in neuroblastoma patients.

Berthold F, Sahin K, Hero B, Christiansen H, Gehring M, Harms D, Horz S, Lampert F, Schwab M, Terpe J. Berthold F, et al. Among authors: gehring m. Eur J Cancer. 1997 Oct;33(12):2092-7. doi: 10.1016/s0959-8049(97)00237-2. Eur J Cancer. 1997. PMID: 9516860

2

The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.

Gehring M, Berthold F, Edler L, Schwab M, Amler LC. Gehring M, et al. Cancer Res. 1995 Nov 15;55(22):5366-9. Cancer Res. 1995. PMID: 7585602

3

Genetic stability of microsatellites in human neuroblastomas.

Gehring M, Berthold F, Schwab M, Amler L. Gehring M, et al. Int J Oncol. 1994 May;4(5):1043-5. doi: 10.3892/ijo.4.5.1043. Int J Oncol. 1994. PMID: 21567017

4

MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells.

Corvi R, Amler LC, Savelyeva L, Gehring M, Schwab M. Corvi R, et al. Among authors: gehring m. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5523-7. doi: 10.1073/pnas.91.12.5523. Proc Natl Acad Sci U S A. 1994. PMID: 8202521 Free PMC article.

5

Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.

Takayama H, Suzuki T, Mugishima H, Fujisawa T, Ookuni M, Schwab M, Gehring M, Nakamura Y, Sugimura T, Terada M, et al. Takayama H, et al. Among authors: gehring m. Oncogene. 1992 Jun;7(6):1185-9. Oncogene. 1992. PMID: 1594247

6

Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system.

Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, Petersen I, Höll T, Wiestler OD, Kleihues P. Ohgaki H, et al. Among authors: gehring m. Mol Carcinog. 1993;8(2):74-80. doi: 10.1002/mc.2940080203. Mol Carcinog. 1993. PMID: 8397797

7

Genetic separation of GvL and GvH reactivity in new recombinant-inbred tumor-resistant mouse strains.

Schirrmacher V, Griesbach A, Gehring M, Lehr B. Schirrmacher V, et al. Among authors: gehring m. Int J Oncol. 1996 Jun;8(6):1035-43. doi: 10.3892/ijo.8.6.1035. Int J Oncol. 1996. PMID: 21544461

8

Type and frequency of p53 mutations in tumors of the nervous system and its coverings.

Kleihues P, Ohgaki H, Eibl RH, Reichel MB, Mariani L, Gehring M, Petersen I, Höll T, von Deimling A, Wiestler OD, et al. Kleihues P, et al. Among authors: gehring m. Recent Results Cancer Res. 1994;135:25-31. doi: 10.1007/978-3-642-85039-4_4. Recent Results Cancer Res. 1994. PMID: 8047694 Review. No abstract available.

9

Defining the role of radiosurgery in the management of brain metastases.

Mehta MP, Rozental JM, Levin AB, Mackie TR, Kubsad SS, Gehring MA, Kinsella TJ. Mehta MP, et al. Among authors: gehring ma. Int J Radiat Oncol Biol Phys. 1992;24(4):619-25. doi: 10.1016/0360-3016(92)90706-n. Int J Radiat Oncol Biol Phys. 1992. PMID: 1429083

10

Treatment of arteriovenous malformations with stereotactic radiosurgery employing both magnetic resonance angiography and standard angiography as a database.

Petereit D, Mehta M, Turski P, Levin A, Strother C, Mistretta C, Mackie R, Gehring M, Kubsad S, Kinsella T. Petereit D, et al. Among authors: gehring m. Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):309-13. doi: 10.1016/0360-3016(93)90353-w. Int J Radiat Oncol Biol Phys. 1993. PMID: 8420879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters